Legislative Research: US HB7667 | 2021-2022 | 117th Congress
Other Sessions
| Session | Title/Description | Last Action |
|---|---|---|
| 2023-2024 118th Congress (Introduced) | To expand the seniors farmers' market program to include maple syrup. [HB7667 2023 Detail][HB7667 2023 Text][HB7667 2023 Comments] | 2024-03-13 Referred to the House Committee on Agriculture. |
| 2021-2022 117th Congress (Engrossed - Dead) | To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes. [HB7667 2021 Detail][HB7667 2021 Text][HB7667 2021 Comments] | 2022-06-09 Received in the Senate. |
| 2019-2020 116th Congress (Introduced - Dead) | Provides FY2021 appropriations to the Department of Commerce, the Department of Justice (DOJ), the science agencies, and several related agencies. The bill provides appropriations to the Department of Commerce for the International Trade Administrati... [HB7667 2019 Detail][HB7667 2019 Text][HB7667 2019 Comments] | 2020-07-16 Placed on the Union Calendar, Calendar No. 366. |
References Online
| Search Phrase | Web | News | Financial | Financial | Encylopedia | Biography | BioGuide |
|---|---|---|---|---|---|---|---|
| [US Congress HB7667] | Google Web | Google News | |||||
| [Representative Anna Eshoo US] | Google Web | Google News | OpenSecrets | FollowTheMoney | Ballotpedia | VoteSmart | BioGuide |
| [Representative Brett Guthrie US] | Google Web | Google News | OpenSecrets | FollowTheMoney | Ballotpedia | VoteSmart | BioGuide |
| [Representative Frank Pallone US] | Google Web | Google News | OpenSecrets | FollowTheMoney | Ballotpedia | VoteSmart | BioGuide |
| [Representative Cathy McMorris Rodgers US] | Google Web | Google News | OpenSecrets | FollowTheMoney | Ballotpedia | VoteSmart | BioGuide |
Legislative Citation
APA
US HB7667 | 2021-2022 | 117th Congress. (2022, June 09). LegiScan. Retrieved May 22, 2024, from https://legiscan.com/US/bill/HB7667/2021
MLA
"US HB7667 | 2021-2022 | 117th Congress." LegiScan. LegiScan LLC, 09 Jun. 2022. Web. 22 May. 2024. <https://legiscan.com/US/bill/HB7667/2021>.
Chicago
"US HB7667 | 2021-2022 | 117th Congress." June 09, 2022 LegiScan. Accessed May 22, 2024. https://legiscan.com/US/bill/HB7667/2021.
Turabian
LegiScan. US HB7667 | 2021-2022 | 117th Congress. 09 June 2022. https://legiscan.com/US/bill/HB7667/2021 (accessed May 22, 2024).
Subjects
Same As/Similar To
| Bill | Relationship | Date | Title | Last Action |
|---|---|---|---|---|
| HB2565 | Related | 2021-04-16 | FDA Modernization Act of 2021 | Referred to the Subcommittee on Health. |
| HB6888 | Related | 2022-03-02 | Helping Experts Accelerate Rare Treatments Act of 2022 | Referred to the Subcommittee on Health. |
| HB6980 | Related | 2022-03-09 | To direct the Secretary of Health and Human Services to conduct a pilot program under which the Secretary increases the conduct of unannounced inspections of foreign human drug establishments and evaluates the differences between inspections of domestic and foreign human drug establishments, including the impact of announcing inspections to persons who own or operate foreign human drug establishments in advance of an inspection. | Referred to the Subcommittee on Health. |
| HB7006 | Related | 2022-03-10 | INSPECTIONS Act Improving the Nation’s Safe Pharmaceuticals and Excipients by Creating Tools for Inspecting and Overseeing Needed Supplies Act | Referred to the Subcommittee on Health. |
| HB7032 | Related | 2022-03-10 | Increasing Transparency in Generic Drug Applications Act of 2022 | Referred to the Subcommittee on Health. |
| HB7035 | Related | 2022-03-10 | Biologics Market Transparency Act of 2022 | Referred to the Subcommittee on Health. |
| HB7084 | Related | 2022-03-16 | PATCH Act of 2022 Protecting and Transforming Cyber Health Care Act of 2022 | Referred to the Subcommittee on Health. |
| HB7649 | Related | 2022-05-03 | To direct the Secretary of Health and Human Services to open a public docket for the submission of public comments regarding factors that should be taken into consideration when reviewing a proposed modification to an approved risk evaluation and mitigation strategy, and for other purposes. | Referred to the House Committee on Energy and Commerce. |
| HB7658 | Related | 2022-05-03 | To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships. | Referred to the House Committee on Energy and Commerce. |
| HB7679 | Related | 2022-05-06 | To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the authority to grant certain exemptions, and for other purposes. | Referred to the House Committee on Energy and Commerce. |
| SB2952 | Related | 2021-10-07 | FDA Modernization Act of 2021 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| SB3478 | Related | 2022-01-11 | GAIN TOOLS Act of 2022 Generating Antibiotic Incentives Now Through Opening Opportunities to Leverage Science Act of 2022 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| SB3983 | Related | 2022-03-31 | PATCH Act | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| SB4152 | Related | 2022-05-05 | A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships. | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| HB6988 | Related | 2022-03-09 | Drug Manufacturing Innovation Act of 2022 | Referred to the Subcommittee on Health. |
| SB4351 | Related | 2022-06-06 | Enhanced Access to Affordable Medicines Act of 2022 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| SB4302 | Related | 2022-05-25 | Biologics Market Transparency Act of 2022 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709) |
| SB4333 | Related | 2022-05-26 | CLEAR Act Consistent Legal Evaluation And Regulation of Medical Products Act | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| SB4338 | Related | 2022-05-26 | Increasing Transparency in Generic Drug Applications Act | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| SB4535 | Related | 2022-07-14 | FDASRA Act of 2022 Food and Drug Administration Simple Reauthorization Act of 2022 Biosimilar User Fee Amendments of 2022 Generic Drug User Fee Amendments of 2022 Medical Device User Fee Amendments of 2022 Prescription Drug User Fee Amendments of 2022 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| HB9297 | Related | 2022-11-16 | Pre-Approval Information Exchange Act of 2022 | Referred to the Subcommittee on Health. |
